Richard Alan Smith

Title: The Innovations of Richard Alan Smith

Introduction

Richard Alan Smith is a notable inventor based in La Jolla, California. He has made significant contributions to the field of pharmacology, particularly through his innovative patents. With a total of 10 patents to his name, Smith has focused on developing alternatives to existing medications, enhancing their efficacy and safety.

Latest Patents

Among his latest patents, one notable invention is the development of analogs of dextromethorphan with balanced receptor activities. These substituted analogs demonstrate substantial binding affinity at both NMDA and sigma-1 receptors. They are designed to be degraded by human liver enzymes more slowly than dextromethorphan, making them useful alternatives that provide similar benefits without the need for co-administration of a cytochrome P-450 enzyme inhibitor. Another significant patent involves antisense modulation of superoxide dismutase 1, soluble. This invention includes antisense compounds and methods for modulating the expression of superoxide dismutase 1, which can be crucial for treating diseases associated with its expression.

Career Highlights

Throughout his career, Richard Alan Smith has worked with various organizations, including the Center for Neurologic Study. His work has been instrumental in advancing the understanding and treatment of neurological conditions.

Collaborations

Smith has collaborated with notable individuals in his field, including Gerald J Yakatan and Laura E Pope. These partnerships have contributed to the success of his innovative projects and patents.

Conclusion

Richard Alan Smith's contributions to pharmacology through his patents reflect his dedication to improving medical treatments. His innovative approaches continue to influence the field and offer promising alternatives for patients.